Beacon Pharmaceuticals PLC, a listed company in the pharmaceuticals and chemicals sector of the capital market, has appointed a new Managing Director (MD). The company’s board of directors made the appointment after considering all relevant factors.

The information was disclosed on Wednesday (17 December), according to sources at the Dhaka Stock Exchange (DSE) and the Chittagong Stock Exchange (CSE).

According to the disclosure, Ulfat Karim has been appointed as the Managing Director of the company. He previously served as the company’s Chief Operating Officer (COO) and as a director. He has been performing the duties of Managing Director since 14 October.

Beacon Pharmaceuticals PLC was listed on the capital market in 2010. The ‘A’ category company has a paid-up capital of Tk 2.31 billion, with a total of 231 million shares. As of 30 November this year, sponsors and directors held 39.86% of the company’s shares, institutional investors 38.19%, and general investors 21.95%.